APIMEDS PHARMACEUTICALS US, INC. (APUS) Net income 2023–2025
APIMEDS PHARMACEUTICALS US, INC. (APUS) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$6.0MFY2025 · since FY2023: -$777,694 → -$6.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.0M | -331.7% |
| FY2024 | -$1.4M | -78.7% |
| FY2023 | -$777,694 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More APUS financial trends
APUS RevenueAPUS Net marginAPUS Gross profitAPUS Gross marginAPUS Operating incomeAPUS Operating marginAPUS Operating cash flowAPUS Free cash flowAPUS Capital expendituresAPUS Return on equityAPUS Stock buybacksAPUS Dividends paidAPUS Total assetsAPUS Total liabilitiesAPUS Shareholders’ equityAPUS overview →